METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation

Mol Cell. 2020 Aug 6;79(3):425-442.e7. doi: 10.1016/j.molcel.2020.06.017. Epub 2020 Jul 1.

Abstract

Double-strand breaks (DSBs) are the most deleterious DNA lesions, which, if left unrepaired, may lead to genome instability or cell death. Here, we report that, in response to DSBs, the RNA methyltransferase METTL3 is activated by ATM-mediated phosphorylation at S43. Phosphorylated METTL3 is then localized to DNA damage sites, where it methylates the N6 position of adenosine (m6A) in DNA damage-associated RNAs, which recruits the m6A reader protein YTHDC1 for protection. In this way, the METTL3-m6A-YTHDC1 axis modulates accumulation of DNA-RNA hybrids at DSBs sites, which then recruit RAD51 and BRCA1 for homologous recombination (HR)-mediated repair. METTL3-deficient cells display defective HR, accumulation of unrepaired DSBs, and genome instability. Accordingly, depletion of METTL3 significantly enhances the sensitivity of cancer cells and murine xenografts to DNA damage-based therapy. These findings uncover the function of METTL3 and YTHDC1 in HR-mediated DSB repair, which may have implications for cancer therapy.

Keywords: ATM; DDR; DNA-RNA hybrids; DSB; METTL3; YTHDC1; cancer therapy; genome stability; homologous recombination; m6A.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / analogs & derivatives*
  • Adenosine / metabolism
  • Animals
  • Antibiotics, Antineoplastic / pharmacology
  • Ataxia Telangiectasia Mutated Proteins / genetics
  • Ataxia Telangiectasia Mutated Proteins / metabolism
  • BRCA1 Protein / genetics
  • BRCA1 Protein / metabolism
  • Bleomycin / pharmacology
  • Cell Line, Tumor
  • DNA / genetics
  • DNA / metabolism
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism
  • Epithelial Cells / pathology
  • Female
  • HEK293 Cells
  • Head and Neck Neoplasms / drug therapy
  • Head and Neck Neoplasms / genetics*
  • Head and Neck Neoplasms / mortality
  • Head and Neck Neoplasms / pathology
  • Humans
  • Methyltransferases / genetics*
  • Methyltransferases / metabolism
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Nerve Tissue Proteins / genetics*
  • Nerve Tissue Proteins / metabolism
  • Nucleic Acid Hybridization
  • Osteoblasts / drug effects
  • Osteoblasts / metabolism
  • Osteoblasts / pathology
  • Phosphorylation
  • Protein Isoforms / genetics
  • Protein Isoforms / metabolism
  • RNA Splicing Factors / genetics*
  • RNA Splicing Factors / metabolism
  • Rad51 Recombinase / genetics
  • Rad51 Recombinase / metabolism
  • Recombinational DNA Repair / drug effects*
  • Ribonuclease H / genetics
  • Ribonuclease H / metabolism
  • Squamous Cell Carcinoma of Head and Neck / drug therapy
  • Squamous Cell Carcinoma of Head and Neck / genetics*
  • Squamous Cell Carcinoma of Head and Neck / mortality
  • Squamous Cell Carcinoma of Head and Neck / pathology
  • Survival Analysis
  • Xenograft Model Antitumor Assays

Substances

  • Antibiotics, Antineoplastic
  • BRCA1 Protein
  • BRCA1 protein, human
  • Nerve Tissue Proteins
  • Protein Isoforms
  • RNA Splicing Factors
  • YTHDC1 protein, human
  • Bleomycin
  • Zeocin
  • DNA
  • N-methyladenosine
  • Methyltransferases
  • METTL3 protein, human
  • ATM protein, human
  • Ataxia Telangiectasia Mutated Proteins
  • RAD51 protein, human
  • Rad51 Recombinase
  • Ribonuclease H
  • ribonuclease HI
  • Adenosine